Management of Bradyarrhythmias in Heart Failure: A Tailored Approach

  • Daniele MasaroneEmail author
  • Ernesto Ammendola
  • Anna Rago
  • Rita Gravino
  • Gemma Salerno
  • Marta Rubino
  • Tommaso Marrazzo
  • Antonio Molino
  • Paolo Calabrò
  • Giuseppe Pacileo
  • Giuseppe Limongelli
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1067)


Patients with heart failure (HF) may develop a range of bradyarrhythmias including sinus node dysfunction, various degrees of atrioventricular block, and ventricular conduction delay. Device implantation has been recommended in these patients, but the specific etiology should be sought as it may influence the choice of the type of device required (pacemaker vs. implantable cardiac defibrillator). Also, pacing mode must be carefully set in patients with heart failure (HF) and left ventricular systolic dysfunction.

In this chapter, we summarize the knowledge required for a tailored approach to bradyarrhythmias in patients with heart failure.


Heart failure reduced ejection fraction Heart failure preserved ejection fraction Bradyarrhytmias Implantable cardioverted defibrillator Pacemaker Cardiomyopathies 


  1. Adan V, Crown LA (2003) Diagnosis and treatment of sick sinus syndrome. Am Fam Physician 67:1725–1732PubMedGoogle Scholar
  2. Algalarrondo V, Dinanian S, Juin C et al (2012) Prophylactic pacemaker implantation in familial amyloid polyneuropathy. Heart Rhythm 9:1069–1075CrossRefPubMedGoogle Scholar
  3. Auricchio A, Salo RW (1997) Acute hemodynamic improvement by pacing in patients with severe congestive heart failure. Pacing Clin Electrophysiol 20:313–319CrossRefPubMedGoogle Scholar
  4. Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237CrossRefPubMedGoogle Scholar
  5. Barold SS, Hayes DL (2001) Second-degree atrioventricular block: a reappraisal. Mayo Clin Proc 76:44–57CrossRefPubMedGoogle Scholar
  6. Barra SN, Providência R, Paiva L et al (2012) A review on the advanced atrioventricular block in young or middle-aged adults. Pacing Clin Electrophysiol 35:1395–1405CrossRefPubMedGoogle Scholar
  7. Batra AS, Epstein D, Silka MJ (2003) The clinical course of acquired complete heart block in children with acute myocarditis. Pediatr Cardiol 24:495–497CrossRefPubMedGoogle Scholar
  8. Bayés de Luna A (2011) Passive arrhythmias, 1st edn. Wiley-Blackwell, OxfordGoogle Scholar
  9. Bharati S, Goldschlager N, Kusumoto F et al (2012) Sinus node dysfunction. In: Camm AJ, Saksena S (eds) Electrophysiological disorders of the heart, 2nd edn. Elsevier Churchill-Livingstone, Philadelphia, pp 207–226Google Scholar
  10. Bindoff L (2003) Mitochondria and the heart. Eur Heart J 24:221–224CrossRefPubMedGoogle Scholar
  11. Birnie DH, Sauer WH, Bogun F et al (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:1305–1323CrossRefPubMedGoogle Scholar
  12. Brignole M (2002) Sick sinus syndrome. Clin Geriatr Med 18:211–227CrossRefPubMedGoogle Scholar
  13. Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Europace 15:1070–1118CrossRefPubMedGoogle Scholar
  14. Cattin ME, Muchir A, Bonne G (2013) ‘State-of-the-heart’ of cardiac laminopathies. Curr Opin Cardiol 28:297–304CrossRefPubMedGoogle Scholar
  15. Choudhury M, Boyett MR, Morris GM (2015) Biology of the sinus node and its disease. Arrhythm Electrophysiol Rev 4:28–34CrossRefPubMedPubMedCentralGoogle Scholar
  16. Cleland JG, Swedberg K, Cohen-Solal A et al (2000) The Euro Heart Failure Survey of the EUROHEART survey program. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for the Health Economics University of York. Eur J Heart Fail 2:123–132CrossRefPubMedGoogle Scholar
  17. Dobrzynski H, Boyett MR, Anderson RH (2007) New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation 115:1921–1932CrossRefPubMedGoogle Scholar
  18. Dresing TJ, Natale A (2001) Congestive heart failure treatment: the pacing approach. Heart Fail Rev 6:15–25CrossRefPubMedGoogle Scholar
  19. Falk RH (2005) Diagnosis and management of the cardiac amyloidoses. Circulation 112:2047–2060CrossRefPubMedGoogle Scholar
  20. Finsterer J, Stöllberger C, Keller H (2012) Arrhythmia-related work up in hereditary myopathies. J Electrocardiol 45:376–384CrossRefPubMedGoogle Scholar
  21. Finsterer J, Stöllberger C, Maeztu C (2016) Sudden cardiac death in neuromuscular disorders. Int J Cardiol 203:508–515CrossRefPubMedGoogle Scholar
  22. García Ropero Á, Aceña Navarro Á, Farré Muncharaz J (2015) Cardiac amyloidosis and pacemakers: could devices delay diagnosis? Rev Esp Cardiol 68:253–259CrossRefGoogle Scholar
  23. Garman SC, Garboczi DN (2004) The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. J Mol Biol 337:319–335CrossRefPubMedGoogle Scholar
  24. Groh WJ (2012) Arrhythmias in the muscular dystrophies. Heart Rhythm 9:1890–1895CrossRefPubMedGoogle Scholar
  25. Haines DE, Beheiry S, Akar JG et al (2014) Heart Rythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety. Heart Rhythm 11:19–23CrossRefGoogle Scholar
  26. Hamzeh N, Steckman DA, Sauer WH, Judson MA (2015) Pathophysiology and clinical management of cardiac sarcoidosis. Nat Rev Cardiol 12:278–288CrossRefPubMedGoogle Scholar
  27. Hermans MC, Pinto YM, Merkies IS et al (2010) Hereditary muscular dystrophies and the heart. Neuromuscul Disord 20:479–492CrossRefPubMedGoogle Scholar
  28. Josephson ME (2008) Sinus node function. In: Clinical cardiac electrophysiology: techniques and interpretations, 4th edn. Lippincott, Williams, & Wilkins, Philadelphia, pp 69–92Google Scholar
  29. Kandolin R, Lehtonen J, Kupari M (2011) Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ Arrhythm Electrophysiol 4:303–309CrossRefPubMedGoogle Scholar
  30. Kim JS, Judson MA, Donnino R (2009) Cardiac sarcoidosis. Am Heart J 157:9–21CrossRefPubMedGoogle Scholar
  31. Kim JH, Lee BH, Hyang Cho J et al (2016) Long-term enzyme replacement therapy for Fabry disease: efficacy and unmet needs in cardiac and renal outcomes. J Hum Genet 61:923–929CrossRefPubMedGoogle Scholar
  32. Køber L, Thune JJ, Nielsen JC et al (2016) Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 375:1221–1230CrossRefPubMedGoogle Scholar
  33. Kumar S, Barbhaiya C, Nagashima K et al (2015) Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Circ Arrhythm Electrophysiol 8:87–93CrossRefPubMedGoogle Scholar
  34. Limongelli G, Masarone D, D’Alessandro R, Elliott PM (2012) Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course. Futur Cardiol 8:71–88CrossRefGoogle Scholar
  35. Limongelli G, D’Alessandro R, Maddaloni V et al (2013) Skeletal muscle involvement in cardiomyopathies. J Cardiovasc Med 14:837–861CrossRefGoogle Scholar
  36. Limongelli G, Masarone D, Pacileo G (2016) Mitochondrial disease and the heart. Heart 1:12–25Google Scholar
  37. Linhart A, Kampmann C, Zamorano JL et al (2007) Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. Eur Heart J 28:1228–1235CrossRefPubMedGoogle Scholar
  38. Link MS, Berkow LC, Kudenchuk PJ et al (2015) Part 7: adult advanced cardiovascular life support: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 132:444–464CrossRefGoogle Scholar
  39. Lo R, Menzies DJ, Archer H, Cohen TJ (2003) Complete heart block due to Lyme carditis. J Invasive Cardiol 15:367–369PubMedGoogle Scholar
  40. Lucon A, Palud L, Pavin D et al (2013) Very late effects of dual chamber pacing therapy for obstructive hypertrophic cardiomyopathy. Arch Cardiovasc Dis 106:373–381CrossRefPubMedGoogle Scholar
  41. Luu M, Stevenson LW, Brunken RC et al (1989) Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 80:1675–1680CrossRefPubMedGoogle Scholar
  42. Mangrum JM, DiMarco JP (2000) The evaluation and management of bradycardia. N Engl J Med 342:703–709CrossRefPubMedGoogle Scholar
  43. Manios EG, Kanoupakis EM, Mavrakis HE et al (2001) Sinus pacemaker function after cardioversion of chronic atrial fibrillation: is sinus node remodeling related with recurrence? J Cardiovasc Electrophysiol 12:800–806CrossRefPubMedGoogle Scholar
  44. Masarone D, Limongelli G, Rubino M et al (2017) Management of arrhythmias in heart failure. J Cardiovasc Dev Dis 4:1–20CrossRefGoogle Scholar
  45. Mathew V, Olson LJ, Gertz MA et al (1997) Symptomatic conduction system disease in cardiac amyloidosis. Am J Cardiol 80:1491–1492CrossRefPubMedGoogle Scholar
  46. McVay MR (1984) Atrioventricular block a review. S D J Med 37:21–26PubMedGoogle Scholar
  47. Montaigne D, Pentiah AD (2015) Mitochondrial cardiomyopathy and related arrhythmias. Card Electrophysiol Clin 7:293–301CrossRefPubMedGoogle Scholar
  48. Morris GM, Kalman JM (2014) Fibrosis, electrics and genetics. Perspectives in sinoatrial node disease. Circ J 78:1272–1282CrossRefPubMedGoogle Scholar
  49. Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883CrossRefPubMedGoogle Scholar
  50. Mullins CB, Atkins JM (1976) Prognoses and management of ventricular conduction blocks in acute myocardial infarction. Mod Concepts Cardiovasc Dis 45:129–131PubMedGoogle Scholar
  51. Newman LS, Rose CS, Maier LA (1997) Sarcoidosis. N Engl J Med 336:1224–1234CrossRefPubMedGoogle Scholar
  52. Nicod P, Gilpin E, Dittrich H et al (1988) Long-term outcome in patients with inferior myocardial infarction and complete atrioventricular block. J Am Coll Cardiol 12:589–594CrossRefPubMedGoogle Scholar
  53. O’Mahony C, Elliott P (2010) Anderson-Fabry disease and the heart. Prog Cardiovasc Dis 52:326–335CrossRefPubMedGoogle Scholar
  54. O’Mahony C, Coats C, Cardona M et al (2011) Incidence and predictors of anti-bradycardia pacing in patients with the Anderson-Fabry disease. Europace 13:1781–1788CrossRefPubMedGoogle Scholar
  55. O’Rourke RA (1972) Clinical cardiology: the stokes-Adams syndrome—definition and etiology; mechanisms and treatment. Calif Med 117:96–99PubMedPubMedCentralGoogle Scholar
  56. Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975CrossRefPubMedGoogle Scholar
  57. Priori SG, Blomström-Lundqvist C, Mazzanti A et al (2015) 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 36:2793–2867CrossRefPubMedGoogle Scholar
  58. Rankin J, Ellard S (2006) The laminopathies: a clinical review. Clin Genet 70:261–274CrossRefPubMedGoogle Scholar
  59. Rapezzi C, Quarta CC, Riva L et al (2010) Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol 7:398–408CrossRefPubMedGoogle Scholar
  60. Rapezzi C, Arbustini E, Caforio AL et al (2013) Diagnostic workup in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:1448–1458CrossRefPubMedGoogle Scholar
  61. Rubart M, Zipes DP (2014) Arrhythmias, sudden death, and syncope. In: Libby P, Bonow RO, Mann DL, Zipes D (eds) Braunwald’s heart disease, 10th edn. Saunders Elsevier, Philadelphia, pp 909–921Google Scholar
  62. Schwartzmann D (2014) Atrioventricular block and atrioventricular dissociation. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology: from cell to bedside, 6th edn. Saunders, Philadelphia, pp 485–499Google Scholar
  63. Sinagra G, Anzini M, Pereira NL et al (2016) Myocarditis in clinical practice. Mayo Clin Proc 91:1256–1266CrossRefPubMedGoogle Scholar
  64. Sneddon JF, Camm AJ (1992) Sinus node disease. Current concepts in diagnosis and therapy. Drugs 44:728–737CrossRefPubMedGoogle Scholar
  65. Solbiati M, Costantino G, Casazza G et al (2016) Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. Cochrane Database Syst Rev 4Google Scholar
  66. Stevenson WG, Ellison KE, Sweeney MO et al (2002) Management of arrhythmias in heart failure. Cardiol Rev 10:8–14CrossRefPubMedGoogle Scholar
  67. Sweeney MO, Prinzen FW (2006) A new paradigm for physiologic ventricular pacing. J Am Coll Cardiol 47:282–290CrossRefPubMedGoogle Scholar
  68. Sweeney MO, Hellkamp AS, Ellenbogen KA et al (2003) Mode Selection Trial Investigators. The adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2938CrossRefPubMedGoogle Scholar
  69. Sylvius N, Tesson F (2006) Lamin A/C and cardiac diseases. Curr Opin Cardiol 21:159–165CrossRefPubMedGoogle Scholar
  70. Tans C, Lie KI, Durrer D (1980) Clinical setting and prognostic significance of high degree atrioventricular block in acute inferior myocardial infarction: a study of 144 patients. Am Heart J 99:4–8CrossRefPubMedGoogle Scholar
  71. Tellez JO, Mczewski M, Yanni J et al (2011) Ageing-dependent remodeling of ion channel and Ca2+ clock genes underlying sino-atrial node pacemaking. Exp Physiol 96:1163–1178CrossRefPubMedGoogle Scholar
  72. Tracy CM, Epstein AE, Darbar D et al (2012) 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 12:1784–1800CrossRefGoogle Scholar
  73. Van Rijsingen IA, Arbustini E, Elliott PM et al (2012) Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol 59:493–500CrossRefPubMedGoogle Scholar
  74. Vogler J, Breithardt G, Eckardt L (2012) Bradyarrhythmias and conduction blocks. Rev Esp Cardiol 65:656–667CrossRefPubMedGoogle Scholar
  75. Waller BF, Gering LE, Branyas NA et al (1993) Anatomy, histology, and pathology of the cardiac conduction system – Part III. Clin Cardiol 16:436–442CrossRefPubMedGoogle Scholar
  76. Weatherall DJ, Ledingham JGG, Warrell DA (2010) Amyloidosis. In: Warrell DA, Cox TM, Firth JD (eds) Oxford textbook of medicine, 5th edn. University Press, Oxford, pp 1512–1524Google Scholar
  77. Wilkoff BL, Cook JR, Epstein AE et al (2002) Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288:3115–3122CrossRefPubMedGoogle Scholar
  78. Wung SF (2016) Bradyarrhythmias: clinical presentation, diagnosis, and management. Crit Care Nurs Clin North Am 28:297–308CrossRefPubMedGoogle Scholar
  79. Yilmaz A, Secthem U (2012) Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy. Heart 98:420–428CrossRefPubMedGoogle Scholar
  80. Zoob M, Smith KS (1963) The etiology of complete heart-block. Br Med J 2:1149–1153CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Daniele Masarone
    • 1
    Email author
  • Ernesto Ammendola
    • 1
  • Anna Rago
    • 1
  • Rita Gravino
    • 1
  • Gemma Salerno
    • 1
  • Marta Rubino
    • 1
  • Tommaso Marrazzo
    • 1
  • Antonio Molino
    • 2
    • 3
  • Paolo Calabrò
    • 4
  • Giuseppe Pacileo
    • 1
  • Giuseppe Limongelli
    • 1
    • 4
    • 5
  1. 1.Cardiomyopathies and Heart Failure Unit-Monaldi HospitalNaplesItaly
  2. 2.First Division of Pneumology Monaldi Hospital-University “Federico II”NaplesItaly
  3. 3.UOC Pneumotisiologia – Department of Clinical Medicine and SurgeryFederico II UniversityNaplesItaly
  4. 4.Department of Cardiothoracic SciencesUniversità della Campania “Luigi Vanvitelli”NaplesItaly
  5. 5.Institute of Cardiovascular Sciences – University College of LondonLondonUK

Personalised recommendations